Aclaris Therapeutics, INC. (ACRS) — SC 13G/A Filings
All SC 13G/A filings from Aclaris Therapeutics, INC.. Browse 11 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (11)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Oct 9, 2024
- SC 13G/A Filing — Jul 8, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
BML Investment Partners Amends Aclaris Therapeutics Stake
— Feb 8, 2024 Risk: medium
BML Investment Partners, L.P. has filed an amendment to their Schedule 13G, indicating a change in their beneficial ownership of Aclaris Therapeutics, Inc. comm -
Millennium Management Updates Aclaris Therapeutics Stake
— Feb 1, 2024
Millennium Management LLC, a hedge fund, filed an amended SC 13G/A on February 1, 2024, disclosing its ownership of Aclaris Therapeutics, Inc. common stock as o -
BlackRock Amends Aclaris Therapeutics Stake, Remains Passive Investor
— Jan 25, 2024
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership in Aclaris Therapeutics, Inc. as of December 31, 2023. This filing, an am
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX